Eosinophilic Panniculitis Following the Subcutaneous Injection of Exenatide Extended-Release

Exenatide extended-release was recently developed as an antidiabetic drug; it acts as a glucagon-like peptide-1 receptor agonist. A 54-year-old male visited our clinic complaining of a subcutaneous tender nodule on his left thigh that had developed over the course of 1 week. The patient had received...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Jung-Woo, Park, Kyung-Duck, Lee, Young, Lee, Jeung-Hoon, Hong, Dong-Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992610/
https://www.ncbi.nlm.nih.gov/pubmed/33911742
http://dx.doi.org/10.5021/ad.2020.32.3.230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992610/
https://www.ncbi.nlm.nih.gov/pubmed/33911742
http://dx.doi.org/10.5021/ad.2020.32.3.230

Ejemplares similares